BSEInsider Trading / SAST3 Sept 2026 · 3 Sept 2026, 10:24 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali
Aspira Pathlab & Diagnostics Ltd · 540788
✦ AI SummaryRelated Party
Aspira Pathlab & Diagnostics Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, related to Jay Arvind Bhanushali.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011